Drug recall · April 14, 2021
Mometasone Furoate Topical Solution recall
Why: CGMP Deviaitons
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080
- Lots / codes
a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022
- Quantity
- a) 30 mL: 7724 b) 60 mL: 8064 bottles
- Company
- Cosette Pharmaceuticals, Inc., South Plainfield, NJ
- Distribution
- Nationwide in the US
- Initiated
- March 25, 2021 · Voluntary: Firm initiated
- Classified
- April 7, 2021
- Reported
- April 14, 2021
- Ended
- July 17, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mometasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.